BMS backs Stand Up To Cancer lung research

Share this article:

Bristol-Myers Squibb is kicking in $5 million to support a new lung cancer research “Dream Team.” The money is going toward a new collaboration between the American Cancer Society and the group Stand Up To Cancer.

The BMS contribution covers 20% of the Dream Team's three-year research budget.

This material may not be published, broadcast, rewritten or redistributed in any form without prior authorization. Your use of this website constitutes acceptance of Haymarket Media's Privacy Policy and Terms & Conditions